These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 6121770

  • 1. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E, Hefti F, Wurtman RJ.
    Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
    [Abstract] [Full Text] [Related]

  • 2. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 3. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 4. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G, Abarca J, Bustos V, Riquelme E, Noriega V, Moya C, Campusano J.
    J Neurosci Res; 2009 Aug 01; 87(10):2308-18. PubMed ID: 19326433
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P, Mercuri NB, Sancesario G, Bernardi G.
    Brain; 1993 Apr 01; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [Abstract] [Full Text] [Related]

  • 6. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism.
    Friehs GM, Parker RG, He LS, Haines SJ, Turner DA, Ebner TJ.
    J Neural Transplant Plast; 1991 Apr 01; 2(2):141-56. PubMed ID: 1684115
    [Abstract] [Full Text] [Related]

  • 7. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
    Kim YK, Lim HH, Song YK, Lee HH, Lim S, Han SM, Kim CJ.
    Neurosci Lett; 1991 Apr 01; 384(1-2):133-8. PubMed ID: 15893426
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 01; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 9. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984 May 01; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

  • 10. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Agrawal AK.
    Neurosci Lett; 2006 May 01; 398(1-2):44-9. PubMed ID: 16423459
    [Abstract] [Full Text] [Related]

  • 11. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC, Shin MS, Kim TS, Kim BK, Ko IG, Sung YH, Kim SE, Lee HH, Kim YP, Kim CJ.
    Neurosci Lett; 2007 Aug 09; 423(1):12-7. PubMed ID: 17644250
    [Abstract] [Full Text] [Related]

  • 12. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep 09; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

  • 13. [Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].
    Ugrumov MV.
    J Soc Biol; 2009 Sep 09; 203(1):75-85. PubMed ID: 19358813
    [Abstract] [Full Text] [Related]

  • 14. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
    Ariano MA, Grissell AE, Littlejohn FC, Buchanan TM, Elsworth JD, Collier TJ, Steece-Collier K.
    J Neurosci Res; 2005 Nov 01; 82(3):387-96. PubMed ID: 16180225
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K, Makino H, Ogawa N.
    Exp Neurol; 1997 Aug 01; 146(2):526-35. PubMed ID: 9270064
    [Abstract] [Full Text] [Related]

  • 16. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
    Winkler C, Bentlage C, Nikkhah G, Samii M, Björklund A.
    Exp Neurol; 1999 Feb 01; 155(2):165-86. PubMed ID: 10072293
    [Abstract] [Full Text] [Related]

  • 17. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S.
    Neurochem Int; 2008 Jun 01; 52(7):1332-42. PubMed ID: 18372079
    [Abstract] [Full Text] [Related]

  • 18. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE, Noordhoorn M, Chan EM, Mocsary Z, Camp DM, Whishaw IQ.
    Synapse; 1994 May 01; 17(1):16-25. PubMed ID: 8042143
    [Abstract] [Full Text] [Related]

  • 19. The site of dopamine formation in rat striatum after L-dopa administration.
    Hefti F, Melamed E, Wurtman RJ.
    J Pharmacol Exp Ther; 1981 Apr 01; 217(1):189-97. PubMed ID: 7205652
    [Abstract] [Full Text] [Related]

  • 20. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
    Hefti F, Melamed E, Wurtman RJ.
    Brain Res; 1980 Aug 11; 195(1):123-37. PubMed ID: 6105003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.